scispace - formally typeset
Open AccessJournal ArticleDOI

Effects of Testosterone Treatment in Older Men

Reads0
Chats0
TLDR
In symptomatic men 65 years of age or older, raising testosterone concentrations for 1 year from moderately low to the mid-normal range for men 19 to 40 years ofAge had a moderate benefit with respect to sexual function and some benefit withrespect to mood and depressive symptoms but no benefit with Respect to vitality or walking distance.
Abstract
BackgroundSerum testosterone concentrations decrease as men age, but benefits of raising testosterone levels in older men have not been established. MethodsWe assigned 790 men 65 years of age or older with a serum testosterone concentration of less than 275 ng per deciliter and symptoms suggesting hypoandrogenism to receive either testosterone gel or placebo gel for 1 year. Each man participated in one or more of three trials — the Sexual Function Trial, the Physical Function Trial, and the Vitality Trial. The primary outcome of each of the individual trials was also evaluated in all participants. ResultsTestosterone treatment increased serum testosterone levels to the mid-normal range for men 19 to 40 years of age. The increase in testosterone levels was associated with significantly increased sexual activity, as assessed by the Psychosexual Daily Questionnaire (P<0.001), as well as significantly increased sexual desire and erectile function. The percentage of men who had an increase of at least 50 m in ...

read more

Citations
More filters
Journal ArticleDOI

Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline

TL;DR: It is suggested that when clinicians institute T therapy, they aim at achieving T concentrations in the mid-normal range during treatment with any of the approved formulations, taking into consideration patient preference, pharmacokinetics, formulation-specific adverse effects, treatment burden, and cost.
Journal ArticleDOI

Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies.

TL;DR: The evolution, controversies and challenges in defining sarcopenic obesity are discussed, and current body composition modalities used to assess this condition are presented and current treatment strategies are outlined.
Journal ArticleDOI

Welcome to the ICD-10 code for sarcopenia.

TL;DR: The new ICD‐10‐CM (M62.84) code for sarc Openia represents a major step forward in recognizing sarcopenia as a disease and should lead to an increase in availability of diagnostic tools and the enthusiasm for pharmacological companies to develop drugs for sarc openia.
Journal ArticleDOI

Hormonal replacement in hypopituitarism in adults: An endocrine society clinical practice guideline

TL;DR: Using an evidence-based approach, this guideline addresses important clinical issues regarding the evaluation and management of hypopituitarism in adults, including appropriate biochemical assessments, specific therapeutic decisions to decrease the risk of co-morbidities due to hormonal over-replacements or under-replacement, and managing hypopitsuits during pregnancy, pituitary surgery, and other types of surgeries.
References
More filters
Journal ArticleDOI

Development and validation of brief measures of positive and negative affect: The PANAS scales.

TL;DR: Two 10-item mood scales that comprise the Positive and Negative Affect Schedule (PANAS) are developed and are shown to be highly internally consistent, largely uncorrelated, and stable at appropriate levels over a 2-month time period.
Journal ArticleDOI

The PHQ-9: validity of a brief depression severity measure.

TL;DR: In addition to making criteria-based diagnoses of depressive disorders, the PHQ-9 is also a reliable and valid measure of depression severity, which makes it a useful clinical and research tool.
Book

SF-36 health survey: Manual and interpretation guide

John E. Ware
TL;DR: TheSF-36 is a generic health status measure which has gained popularity as a measure of outcome in a wide variety of patient groups and social and the contribution of baseline health, sociodemographic and work-related factors to the SF-36 Health Survey: manual and interpretation guide is tested.
Journal ArticleDOI

More powerful procedures for multiple significance testing.

TL;DR: Some new, general and simple procedures are discussed and demonstrated by two examples from the medical literature: the neuropsychologic effects of unidentified childhood exposure to lead, and the sleep patterns of sober chronic alcoholics.
Journal ArticleDOI

Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men

TL;DR: Observations of health factor independent, age-related longitudinal decreases in T and free T, resulting in a high frequency of hypogonadal values, suggest that further investigation of T replacement in aged men, perhaps targeted to those with the lowest serum T concentrations, are justified.
Related Papers (5)
Trending Questions (1)
What are the effects of testoboost on testosterone?

The paper discusses the effects of testosterone treatment on older men. It does not mention anything about the effects of "testoboost" on testosterone.